Showing results (101-110 of 321) with videos related to
Sort By:
Pageof 33
European Journal of Medicinal Chemistry|September 18, 2007
Xanthine oxidase-activated prodrugs of thymidine phosphorylase inhibitorsPhilip Reigan, Abdul Gbaj, Ian J Stratford, et al.British Journal of Cancer|June 1, 1994
Magnetic resonance spectroscopic studies on 'real-time' changes in RIF-1 tumour metabolism and blood flow during and after photodynamic therapyJ C Bremner, J K Bradley, I J Stratford, et al.Cancer Research|July 14, 1998
Thymidine phosphorylase moderates thymidine-dependent rescue after exposure to the thymidylate synthase inhibitor ZD1694 (Tomudex) in vitroA V Patterson, D C Talbot, I J Stratford, et al.Clinical Toxicology|December 1, 1981
A biochemical assessment of the neurotoxicity of the radiosensitizing drug misonidazole in the ratG P Rose, A J Dewar, B J Moffett, et al.International Journal of Radiation Oncology, Biology, Physics|July 1, 1986
The radiosensitizing and toxic effects of RSU-1069 on hypoxic cells in a murine tumorD J Chaplin, R E Durand, I J Stratford, et al.Biophysical Journal|July 1, 1997
The effects of synaptic noise on measurements of evoked excitatory postsynaptic response amplitudesL M Wahl, J J Jack, A U Larkman, et al.Bioorganic & Medicinal Chemistry Letters|December 19, 2006
Analogues of 2-crotonyloxymethyl-(4R,5R,6R)-4,5,6-trihydroxycyclohex-2-enone (COTC) with anti-tumor propertiesClaire L Arthurs, Natasha S Wind, Roger C Whitehead, et al.International Journal of Radiation Oncology, Biology, Physics|May 1, 1989
Induction of severe tumor hypoxia by modifiers of the oxygen affinity of hemoglobinG E Adams, I J Stratford, A B Nethersell, et al.Anti-Cancer Drugs|June 1, 1997
Synthesis and cytotoxic activity of indolyl thiazolesC J Moody, J R Roffey, M A Stephens, et al.Oncology Research|January 1, 1997
Targeting gene therapy to cancer: a reviewG U Dachs, G J Dougherty, I J Stratford, et al.Pageof 33